Accuray (Nasdaq:ARAY) shares rose this morning on second-quarter results that topped the consensus forecast. ARAY shares ticked up 12.1% at $2.75 apiece. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 14.4%. The Sunnyvale, California–based radiation oncology company posted losses of $1.9 million. That amounts to losses […]
Accuray Inc.
Accuray partners with Limbus AI on adaptive radiotherapy
Accuray (Nasdaq:ARAY) and Limbus AI announced today that they are partnering to augment Accuray’s adaptive radiotherapy capabilities. The partnership aims to leverage Limbus’ artificial intelligence (AI)-driven auto contouring algorithms to enable a streamlined treatment planning process. Sunnyvale, California-based Accuray and Saskatchewan, Canada-based Limbus AI anticipate an integrated offering will be made available beginning in 2023, […]
Accuray names Sandeep Chalke as chief commercial officer
Accuray (NSDQ:ARAY) today announced it appointed Sandeep Chalke as senior VP and chief commercial officer, effective May 16. Chalke will report to President and forthcoming CEO Suzanne Winter and will be responsible for the global commercial, product development, R&D and engineering functions of the Sunnyvale, California-based company. “I am thrilled to join the Accuray team and […]
10-year data shows sustained pain relief with Accuray’s CyberKnife system
Accuray (NSDQ:ARAY) announced today that long-term follow-up data demonstrated pain relief after image-guided robotic radiosurgery treatments with its CyberKnife system. The data from a study of men and women with trigeminal neuralgia (TN) showed that 72% continued to experience pain relief 10 years after receiving the treatments delivered with the CyberKnife system. “Robotic Image-Guided Radiosurgery […]
Accuray dips despite Q2 revenue beat, raised guidance
Accuray (NSDQ:ARAY) shares dipped this morning despite second-quarter results that beat the consensus sales forecast. The Sunnyvale, California–based radiation oncology company posted profits of $179,000, breaking even at $0.00 on earnings per share, on sales of $116.3 million for the three months ended Dec. 31, 2021, for a major bottom-line slide from profits of $4.8 […]
Accuray posts Street-beating Q1
Accuray (NSDQ:ARAY) shares were slightly down after hours today on first-quarter results that beat the consensus forecast. The Sunnyvale, California-based radiation oncology company posted losses of $1 million, or 1¢ per share, on sales of $107.4 million for the three months ended Sept. 30, 2021, seeing its bottom line slide into the red despite sales […]
Accuray beats The Street in Q4
Accuray (NSDQ:ARAY) shares dipped this morning despite fourth-quarter results that beat the consensus forecast. The Sunnyvale, Calif.-based radiation oncology company posted losses of -$11.1 million, or -12¢ per share, on sales of $110.9 million for the three months ended June 30, 2021, for a massive bottom-line slide from losses of $152,000 this time last year […]
Accuray promotes exec Suzanne Winter to president
Accuray (NSDQ:ARAY) announced that it promoted executive Suzanne Winter to president, effective as of July 1, 2021. Winter, who previously served as Sunnyvale, Calif.-based Accuray’s chief commercial officer and SVP of R&D & medical & scientific affairs, will continue to report to CEO Joshua Levine. “Suzanne has had a significant impact on Accuray’s product portfolio […]
Accuray names chief medical, technology officer
Accuray (NSDQ:ARAY) today said it has appointed Dr. Jean-Philippe Pignol as its chief medical and technology officer, effective April 15. Pignol will lead the company’s scientific and clinical research activities, develop strategic collaborations, evaluate new technologies and serve as the representative with important industry partners. “We’re thrilled to welcome Dr. Pignol, whose rich and unique […]
Accuray beats The Street in Q2 earnings
Accuray (NSDQ:ARAY) yesterday posted second-quarter results that beat the consensus forecast on Wall Street. The Sunnyvale, Calif.-based radiation oncology company reported profits of $4.8 million, or 5¢ per share, on sales of $97.5 million for the three months ended Dec. 31, 2020, for a bottom-line slide of -55.5% sales loss of -1.4% compared with Q2 2020. […]
Accuray ticks up on Street-beating Q1
Accuray (NSDQ:ARAY) shares ticked up today on first-quarter results that came in ahead of the consensus forecast. The Sunnyvale, Calif.-based radiotherapy device maker posted profits of $402,000, breaking even on a per-share basis, on sales of $85.3 million for the three months ended Sept. 30, 2020, for a bottom-line gain from losses of more than -$9.3 […]
